INFLUENZA B VIRUS - ANVISA Registration 81905510060
Access comprehensive regulatory information for INFLUENZA B VIRUS in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 81905510060 and manufactured by manufacturer not specified. The registration is held by GMRB COMÉRCIO DE PRODUTOS MÉDICOS E DIAGNÓSTICOS LTDA with validity until Mar 10, 2034.
This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 companies making the same product including R-BIOPHARM AG, NOVATEC IMMUNDIAGNOSTICA GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Related Devices (2)
Registration Details
81905510060
25351249760202288
34255136000164
Company Information
Dates and Status
Nov 28, 2022
10/03/2034
09/18/2025 19:00:01
VÍRUS INFLUENZA B
Micropartículas Influenza B IgM CLIA
Not specified
80102513468
Jun 30, 2025
VÍRUS INFLUENZA B
Micropartículas Influenza B IgM CLIA
AUTOBIO DIAGNOSTICS CO., LTD
80102513468
Jun 30, 2025
VÍRUS INFLUENZA B
SERION ELISA classic Influenza B IgG
Not specified
81905510073
Nov 28, 2022
VÍRUS INFLUENZA B
SERION ELISA classic Influenza B IgG
INSTITUT VIRION\SERION GMBH
81905510073
Nov 28, 2022
VÍRUS INFLUENZA B
INFLUENZA B-CHECK-1
Not specified
81086830020
Sep 14, 2020

